Relmada Therapeutics Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Relmada Therapeutics kazanç ve gelirinin sırasıyla yıllık 5.2% ve 75.4% oranında artması tahmin edilirken, EPS'nin yıllık 21.5% oranında büyümesi bekleniyor.
Anahtar bilgiler
5.2%
Kazanç büyüme oranı
21.5%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 23.6% |
Gelir büyüme oranı | 75.4% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 05 Nov 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
Mar 21Here's Why We're Watching Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Situation
Mar 13Relmada: Phase 3 Data Did Not Live Up To Phase 2 Benchmark
Jan 14Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Deliver On Growth Plans?
Dec 04Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
Aug 29We're Keeping An Eye On Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
May 07We're Keeping An Eye On Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
Dec 15Relmada Downgraded at Truist, Guggenheim in wake of depression candidate failure
Oct 14Relmada Therapeutics: Initiating With A Strong BUY; Key Phase 3 Short-Term Catalysts Lined Up
Sep 14Relmada Therapeutics receives FDA fast track tag for REL-1017 to treat depression
Aug 09We're Hopeful That Relmada Therapeutics (NASDAQ:RLMD) Will Use Its Cash Wisely
Jul 14Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Deliver On Growth Plans?
Feb 264 Clinical Catalysts On Tap For Relmada In 2022
Jan 28Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
Nov 04Our First Look At Relmada Therapeutics
Jun 28We're Not Very Worried About Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
Jun 28Here's Why We're Not Too Worried About Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Situation
Mar 09What Percentage Of Relmada Therapeutics, Inc. (NASDAQ:RLMD) Shares Do Insiders Own?
Jan 15Enrollment underway in Relmada Therapeutics' late-stage depression study with REL-1017
Dec 07Relmada Therapeutics (RLMD) Investor Presentation - Slideshow
Dec 02Relmada Therapeutics (RLMD) Investor Presentation - Slideshow
Nov 16Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 20 | -131 | -69 | N/A | 3 |
12/31/2025 | N/A | -100 | -65 | N/A | 3 |
12/31/2024 | N/A | -82 | -55 | N/A | 3 |
6/30/2024 | N/A | -87 | -48 | -48 | N/A |
3/31/2024 | N/A | -94 | -48 | -48 | N/A |
12/31/2023 | N/A | -99 | -52 | -52 | N/A |
9/30/2023 | N/A | -112 | -77 | -77 | N/A |
6/30/2023 | N/A | -129 | -93 | -93 | N/A |
3/31/2023 | N/A | -144 | -101 | -101 | N/A |
12/31/2022 | N/A | -157 | -104 | -104 | N/A |
9/30/2022 | N/A | -153 | -106 | -106 | N/A |
6/30/2022 | N/A | -157 | -100 | -100 | N/A |
3/31/2022 | N/A | -143 | -95 | -95 | N/A |
12/31/2021 | N/A | -126 | -92 | -92 | N/A |
9/30/2021 | N/A | -112 | -61 | -61 | N/A |
6/30/2021 | N/A | -86 | -53 | -53 | N/A |
3/31/2021 | N/A | -71 | -40 | -40 | N/A |
12/31/2020 | N/A | -59 | -28 | -28 | N/A |
9/30/2020 | N/A | -43 | -25 | -25 | N/A |
6/30/2020 | N/A | -30 | -15 | -15 | N/A |
3/31/2020 | N/A | -23 | -14 | -14 | N/A |
12/31/2019 | N/A | -15 | -12 | -12 | N/A |
9/30/2019 | N/A | -18 | -11 | -11 | N/A |
6/30/2019 | N/A | -17 | -10 | -10 | N/A |
3/31/2019 | N/A | -17 | -9 | -9 | N/A |
12/31/2018 | N/A | -17 | -9 | -9 | N/A |
9/30/2018 | N/A | -11 | -7 | -7 | N/A |
6/30/2018 | N/A | -9 | -6 | -6 | N/A |
3/31/2018 | N/A | -7 | N/A | -5 | N/A |
12/31/2017 | N/A | -6 | N/A | -5 | N/A |
9/30/2017 | N/A | -6 | N/A | -5 | N/A |
6/30/2017 | N/A | -6 | N/A | -6 | N/A |
3/31/2017 | N/A | -8 | N/A | -8 | N/A |
12/31/2016 | N/A | -8 | N/A | -10 | N/A |
9/30/2016 | N/A | -9 | N/A | -12 | N/A |
6/30/2016 | N/A | -3 | N/A | -13 | N/A |
3/31/2016 | N/A | 6 | N/A | -15 | N/A |
12/31/2015 | N/A | 6 | N/A | -16 | N/A |
9/30/2015 | N/A | 14 | N/A | -17 | N/A |
6/30/2015 | N/A | -21 | N/A | -16 | N/A |
3/31/2015 | N/A | -55 | N/A | -13 | N/A |
12/31/2014 | N/A | -46 | N/A | -9 | N/A |
9/30/2014 | N/A | -56 | N/A | -5 | N/A |
6/30/2014 | N/A | -28 | N/A | -3 | N/A |
3/31/2014 | N/A | -13 | N/A | -3 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: RLMD önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.
Kazançlar ve Piyasa: RLMD önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.
Yüksek Büyüme Kazançları: RLMD önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.
Gelir ve Pazar: RLMD gelecek yıl gelir elde edemeyeceği tahmin ediliyor.
Yüksek Büyüme Geliri: RLMD gelecek yıl gelir elde edemeyeceği tahmin ediliyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: RLMD 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok